Atlas Trials

Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters

Clinical trial NCT00231153 · COMPLETED

Trial details

NCT number
NCT00231153
Sponsor
Cadence Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Infection
Start date
2005-08-01
Primary completion
2008-06-01
Enrollment
1859

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.